An efficient synthetic approach to cyanocycline A and bioxalomycin β2 via [C+NC+CC] coupling

Journal of the American Chemical Society

Volumn 129, Issue 50, 2007, Pages 15460-15461

  Kaniskan, H Ümit ^a   Garner, Philip ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; BIOXALOMYCIN BETA2; CYANOCYCLINE A; NATURAL PRODUCT; PALLADIUM; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TECHNOLOGY;

ALDEHYDES; CARBON; MOLECULAR STRUCTURE; NAPHTHYRIDINES; NITROGEN; OXAZOLES;

EID: 37849035988     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja077853c     Document Type: Article

References (25)

1. 1-catalyzed endo selective [C+NC+CC] coupling: Garner, P.; Kaniskan, H. Ü.; Hu, J.; Youngs, W. J.; Panzner, M. Org. Lett. 2006, 8, 3647.
2. 1-catalyzed exo selective [C+NC+CC] coupling: Garner, P.; Hu, J.; Parker, C. G.; Youngs, W. J.; Medvetz, D. Tetrahedron Lett. 2007, 48, 3867.
3. Zaccardi, J.; Alluri, M.; Ashcroft, J.; Bernan, V.; Korshalla, J. D.; Morton, G. O.; Siegel, M.; Tsao, R.; Williams, D. R.; Maiese, W.; Ellestad, G. A. J. Org. Chem. 1994, 59, 4045. This paper established that the originally proposed structure of naphthyridinomycin was likely the G-ring hydrolysate and that the natural product is, in fact, bioxalomycin β2.
4. For, a comprehensive review of the chemistry and biology of the saframycin, quinocarcin, and naphthyridinomycin families of tetrahydroisoquinoline antibiotics, see: Scott, J. D.; Williams, R. M. Chem. Rev. 2002, 102, 1669.
5. While the tetrahydroisoquinoline antibiotics were originally believed to act as DNA-damaging, cytotoxins, there is increasing evidence that these molecules also interact with therapeutically relevant proteins: (a) dnacin inhibits dual specificity phosphatase cdc25B: Horiguchi, T.; Nishi, K.; Hakoda, S.; Tanida, S.; Nagata, A.; Okayama, H. Biochem. Pharmacol. 1994, 48, 2139.
6. (b) DX-52-1 inhibits radixin: Kahsai, A. W.; Zhu, S.; Wardrop, D. J.; Lane, W. S.; Fenteany, G. Chem. Biol. 2006, 13, 973.
7. (c) ET-743 inhibits DNA repair proteins: D'Incalci, M.; Erba, E.; Damia, G.; Gallera, E.; Carrassa, L.; Marchini, S.; Mantovani, R.; Tognon, G.; Fruscio, R.; Jimeno, J.; Faircloth, G. T. The Oncologist 2002, 7, 210.
8. Synthesis of rac-cyanocycline A: (a) Evans, D. A.; Illig, C. A.; Saddler, J. C. J. Am. Chem. Soc. 1986, 108, 2478.
9. (b) Fukuyama, T.; Li, L.; Laird, A. A.; Frank, R. K. J. Am. Chem. Soc. 1987, 109, 1587.
10. (c) Illig, C. R. Ph.D. Dissertation, Harvard University, Cambridge, MA, 1987.
11. (d) Li, L. Ph.D. Dissertation, Rice University, Houston, TX, 1989.
12. (e) Synthesis of (+)-naphthyridinomycin: Fukuyama, T. Adv. Heterocycl. Chem. 1992, 2, 189.
13. Other synthetic efforts: (f) Danishefsky, S.; O'Neill, B. T.; Taniyama, E.; Vaughn, K. Tetrahedron Lett. 1984, 25, 4199.
14. (g) Danishefsky, S.; O'Neill, B. T.; Springer, J. T. Tetrahedron Lett. 1984, 25, 4203.
15. (h) Garner, P.; Cox, P. B.; Anderson, J. T.; Protasiewicz, J.; Zaniewski, R. J. Org. Chem. 1997, 62, 493.
16. (i) Movassaghi, M. Ph.D. Dissertation, Harvard University, Cambridge, MA, 2001.
17. (j) Herberich, B.; Kinugawa, M.; Vazquez, A.; Williams, R. M. Tetrahedron Lett. 2001, 42, 543.
18. (k) Mori, K.; Rikimaru, K.; Kan, T.; Fukuyama, T. Org. Lett. 2004, 6, 3095.
19. The bromide corresponding to 1 was prepared by benzylation of the known 5-bromo-2,4-dimetnoxy-3-methylphenol: Marques, M. M.; Pichlmair, M. M. B.; Martin, H. J.; Mulzer, J. Synthesis 2002, 2766.
20. Merino, P.; Lanaspa, A.; Merchan, F. L.; Tejero, T. Tetrahedron: Asymmetry 1998, 9, 629.
21. This compound was conveniently prepared by acylation of Oppolzer's L-camphorsultam with bromoacetyl bromide followed by displacement by azide and hydrogenolysis. See: Kaniskan, H. Ü. Ph.D. Dissertation, Case Western Reserve University, Cleveland, OH, 2007.
22. (a) Pallavicini, M.; Moroni, B.; Bolchi, C.; Cilia, A.; Clementi, F.; Fumagalli, L.; Gotti, C.; Meneghetti, F.; Riganti, L.; Vistoli, G.; Valoti, E. Bioorg. Med. Chem. Lett. 2006, 16, 5610.
23. (b) McManus, H. A.; Fleming, M. J.; Lautens, M. Angew. Chem., Int. Ed. 2007, 46, 433.
24. Pelletier, S. W.; Nowacki, J.; Mody, N. V. Synth. Commun. 1979, 9, 201.
25. Compound 12 has been found to inhibit cell migration, like DX-52-1, and has target overlap with DX-52-1 but has far greater selectivity for one target over another: Fenteany, G. Personal communication. This finding supports our hypothesis that this natural product family - now readily accessible using the strategy disclosed herein - will be useful for protein interrogation and drug development.